IP Library › Granted Patent US 7,846,949
Granted Patent B2
US 7,846,949 · App. 10/589,410 · Granted Dec 7, 2010

Compounds and compositions as LXR modulators

Assignee: IRM LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,846,949
App. No.
10/589,410
Granted
Dec 7, 2010
Kind
B2
Abstract

The invention provides compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with the activity of liver X receptors (LXRs).

Claims (3)

1. A compound selected from:

2. A pharmaceutical composition comprising a therapeutically effective amount of a compound of claim 1 , or pharmaceutically acceptable salt thereof, in combination with a pharmaceutically acceptable excipient.

3. A method for modulation of LXR activity, which method comprises administering to an animal an effective amount of a compound of claim 1 .

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 22, 2008
From: MOLTENI, VALENTINA; LI, XIAOLIN; LIANG, FANG; NABAKKA, JULIET; SAEZ, ENRIQUE; WITYAK, JOHN
To: IRM, LLC
Reel/Frame 020397/0012 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 4, 2007
From: MOLTENI, VALENTINA; LI, XIAOLIN; LIANG, FANG; NABAKKA, JULIET; SAEZ, ENRIQUE; WITYAK, JOHN
To: IRM, LLC
Reel/Frame 019923/0480 →
Continuity (2)
Provisional Application 6054414900 · Feb 11, 2004
Related Publication 20070293547A1 · Dec 20, 2007